Research Expert: Sarah Overall
  • Published: May 2025
  • Pages: 150
  • SKU: IRTNTR70710

  • Latest News- Biosimilars Market: Monoclonal antibodies is expected to lead the Product Type segment during 2025-2029

    The Biosimilars Market is being driven by Price advantage of biosimilars over biologics

    The Biosimilars Market is expected to grow at a CAGR of 34.2% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 117678.1 million. In the global biosimilar market, patient acceptance of biosimilar switching and physician prescribing behavior significantly influence market growth. Many physicians, particularly rheumatologists, often prefer prescribing the bio-originator over biosimilars as the initial or secondary treatment option for rheumatology diseases. This resistance stems from concerns regarding the perceived reduced efficacy of biosimilars compared to the reference product. At the community pharmacy level, substitution of a biosimilar with a bio-originator is authorized in specific countries, primarily in Central and Eastern Europe. Despite an increasing trend in patient and physician adoption of biosimilars, the rate of substitution remains low due to regulatory restrictions in certain regions. 

    Get more information on Biosimilars Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Product Type
      • Monoclonal antibodies
      • Insulin
      • Human growth hormone
      • Others
    • Application
      • Oncology and hematology
      • Endocrinology
      • Immunology
      • Nephrology
    • Manufacturing Type
      • In-house manufacturing
      • Contract manufacturing
    • Geography
      • Europe
        • Germany
        • UK
        • France
      • North America
        • Canada
        • US
      • Asia
        • China
        • Japan
        • South Korea
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Price advantage of biosimilars over biologics
      • Patent expiry of major biologics
      • Government initiatives to increase use of biosimilar medicines

      However, the market also witnesses some limitations, which are as follows:

      • Market access barriers for biosimilars
      • Supply chain challenges of biosimilars
      • Obstacles in giving reimbursement for biosimilars

      Benefits of Buying Global Biosimilars Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Biosimilars Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      219

      Base year

      2024

      Historic period

      2019-2023

      Forecast period

      2025-2029

      Growth momentum & CAGR

      Accelerate at a CAGR of 34.2%

      Market growth 2025-2029

      USD 117678.1 million

      Market structure

      market_structure.ucfirst

      YoY growth 2024-2025(%)

      25.6

      Key countries

      Germany, US, UK, China, Canada, France, South Korea, Japan, Brazil, and UAE

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      The Biosimilars Market encompasses the regulatory landscape, intellectual property considerations, and patent litigation surrounding biosimilar products. Key elements include guidelines for regulatory approval, frameworks for manufacturing technology and analytical methods, clinical endpoint assessment, and data analysis. Market research, analysis, and intelligence provide insights into industry trends, dynamics, innovation, and access initiatives. Quality assurance, control, and risk assessment ensure safety and cost-effectiveness, while supply chain and distribution strategies optimize market penetration. Education programs and awareness campaigns enhance patient safety and understanding.

      Market Research Overview

      The biosimilars market represents a significant segment within the larger pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of these biologically similar alternatives to reference products. Monoclonal antibodies are a key therapeutic area for biosimilars, with increasing demand driven by their efficacy and cost savings compared to original biologics. The regulatory approval process for biosimilars is rigorous, requiring extensive clinical trials and comparisons to the reference product to ensure safety and efficacy. Technavio projects that the global pharmaceuticals market, which includes the revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, will experience growth due to demographic trends, such as an aging population. By 2050, approximately one-quarter of the US population and by 2030 in Europe, are projected to be over the age of 60 years, leading to a greater need for healthcare solutions, including biosimilars.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.